From: Outsmarting trogocytosis to boost CAR NK/T cell therapy
Trogocytic molecules/receptors | Direction | Effects on NK cells fate and/or function | References |
---|---|---|---|
NKG2DLs | Cancer cells to NK cells | Downregulates NKG2D and increases NK cell fratricide | |
m157 | Cancer cells to NK cells | Reduces cytotoxic function and decreases IFN-γ production | |
PD-1 | Cancer cells to NK cells | Reduces NK cell-mediated antitumor immunity | [35] |
HLA-G1 | Cancer cells to NK cells | Promotes acquisition of suppressive function by NK cells that prevents cytotoxic function of other NK cells. | [39] |
MHC II and/or CD80/CD86 | Dendritic cells to NK cells | Suppress T cell-mediated immune response through the lack of functional levels of costimulatory molecules in DC-dressed NK cells | [40] |
CCR7 | Dendritic cells (DCs) and T-cell blasts to NK cells | Promotes migration to lymph nodes | |
CD9 | Cancer cells to NK cells | Facilitates immune escape of intratumoral CD9-dressed NK cells, particularly through reduced antitumor cytokine production and increased pro-angiogenic IL-8 |